Astrazeneca Plc Adr Stock Market Value
| AZN Stock | USD 65.63 1.37 2.13% |
| Symbol | AstraZeneca |
AstraZeneca PLC ADR Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.034 | Dividend Share 2.97 | Earnings Share 2.07 | Revenue Per Share 2.7424 | Quarterly Revenue Growth 0.18 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AstraZeneca PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AstraZeneca PLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AstraZeneca PLC.
| 08/26/2024 |
| 11/24/2024 |
If you would invest 0.00 in AstraZeneca PLC on August 26, 2024 and sell it all today you would earn a total of 0.00 from holding AstraZeneca PLC ADR or generate 0.0% return on investment in AstraZeneca PLC over 90 days. AstraZeneca PLC is related to or competes with Novartis, GlaxoSmithKline PLC, Roche Holding, Bristol Myers, Sanofi ADR, Merck, and Gilead Sciences. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercializatio... More
AstraZeneca PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AstraZeneca PLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AstraZeneca PLC ADR upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.35) | |||
| Maximum Drawdown | 8.5 | |||
| Value At Risk | (3.18) | |||
| Potential Upside | 1.28 |
AstraZeneca PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AstraZeneca PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AstraZeneca PLC's standard deviation. In reality, there are many statistical measures that can use AstraZeneca PLC historical prices to predict the future AstraZeneca PLC's volatility.| Risk Adjusted Performance | (0.20) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | 28.98 |
AstraZeneca PLC ADR Backtested Returns
AstraZeneca PLC ADR secures Sharpe Ratio (or Efficiency) of -0.28, which signifies that the company had a -0.28% return per unit of risk over the last 3 months. AstraZeneca PLC ADR exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AstraZeneca PLC's Mean Deviation of 1.05, standard deviation of 1.48, and Risk Adjusted Performance of (0.20) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.014, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AstraZeneca PLC are expected to decrease at a much lower rate. During the bear market, AstraZeneca PLC is likely to outperform the market. At this point, AstraZeneca PLC ADR has a negative expected return of -0.41%. Please make sure to confirm AstraZeneca PLC's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if AstraZeneca PLC ADR performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
AstraZeneca PLC ADR has very good predictability. Overlapping area represents the amount of predictability between AstraZeneca PLC time series from 26th of August 2024 to 10th of October 2024 and 10th of October 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AstraZeneca PLC ADR price movement. The serial correlation of 0.82 indicates that around 82.0% of current AstraZeneca PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 35.13 |
AstraZeneca PLC ADR lagged returns against current returns
Autocorrelation, which is AstraZeneca PLC stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AstraZeneca PLC's stock expected returns. We can calculate the autocorrelation of AstraZeneca PLC returns to help us make a trade decision. For example, suppose you find that AstraZeneca PLC has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AstraZeneca PLC regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AstraZeneca PLC stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AstraZeneca PLC stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AstraZeneca PLC stock over time.
Current vs Lagged Prices |
| Timeline |
AstraZeneca PLC Lagged Returns
When evaluating AstraZeneca PLC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AstraZeneca PLC stock have on its future price. AstraZeneca PLC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AstraZeneca PLC autocorrelation shows the relationship between AstraZeneca PLC stock current value and its past values and can show if there is a momentum factor associated with investing in AstraZeneca PLC ADR.
Regressed Prices |
| Timeline |
Pair Trading with AstraZeneca PLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.Moving together with AstraZeneca Stock
Moving against AstraZeneca Stock
| 0.89 | GILD | Gilead Sciences | PairCorr |
| 0.88 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.71 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.53 | VRDN | Viridian Therapeutics | PairCorr |
| 0.4 | KZR | Kezar Life Sciences | PairCorr |
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AstraZeneca PLC Correlation, AstraZeneca PLC Volatility and AstraZeneca PLC Alpha and Beta module to complement your research on AstraZeneca PLC. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.